Skip to main content

Table 4 Frequency of late toxicity

From: Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy

 

Grade 0

Grade 1

Grade 2

Grade 3

Grade 4

N (%)

N (%)

N (%)

N (%)

N (%)

Xerostomia

48 (21.9)

107 (48.9)

64 (29.2)

0 (0)

0 (0)

Hearing impairment

75 (34.2)

82 (37.5)

51 (23.3)

4 (1.8)

7 (3.2)

Chronic otitis media

74 (33.8)

72 (32.9)

73 (33.3)

0 (0)

0 (0)

Dysphagia

94 (42.9)

74 (33.8)

50 (22.8)

1 (0.5)

0 (0)

Neck fibrosis

140 (63.9)

71 (32.4)

6 (2.7)

2 (1.0)

0 (0)

Radiation neuropathy

205 (93.6)

14 (6.4)

0 (0)

0 (0)

0 (0)

 Temporal lobe necrosis

209 (95.4)

10 (4.6)

0 (0)

0 (0)

0 (0)

 Cranial nerve palsy

215 (98.2)

4 (1.8)

0 (0)

0 (0)

0 (0)

  1. Graded according to the CTCAE Version 4.03